COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1902: Articles 19011-19020  | Next

The impact of high dose oral cotrimoxazole in patients with COVID-19 with hypoxic respiratory failure requiring non-invasive ventilation: A Case Control Study
Singh, S., John, T., Kumar, P., Quadery, S. R.
10.1101/2021.01.14.21249803 — Posted: 2021-01-15
Detection of SARS-Cov-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.
Rodriguez Serrano, D. A., Roy-Vallejo, E., Zurita Cruz, N. D., Martin Ramirez, A., Rodriguez-Garcia, S. C., Arevalillo-Fernandez, N., Galvan-Roman, J. M., Fontan Garcia-Rodrigo, L., Vega Piris, L., Chicot Llano, M., Arribas Mendez, D., Gonzalez de Marcos, B., Hernando Santos, J., Sanchez Azofra, A., Avalos Perez-Urria, E., Rodriguez-Cortes, P., Esparcia, L., Marcos-Jimenez, A., Sanchez-Alonso, S., Llorente, I., Soriano, J. B., Suarez Fernandez, C., Garcia-Vicuna, R., Ancochea, J., Sanz, J., Munoz-Calleja, C., de la Camara, R., Canabal Berlanga, A., Gonzalez-Alvaro, I., Cardenoso, L.
10.1101/2021.01.14.21249372 — Posted: 2021-01-15
Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection
Silverstein, N. J., Wang, Y., Manickas-Hill, Z., Carbone, C. C., Dauphin, A., Li, J. Z., Walker, B. D., Yu, X. G., Luban, J.
10.1101/2021.01.14.21249839 — Posted: 2021-01-15
A Vital Sign-based Prediction Algorithm for Differentiating COVID-19 Versus Seasonal Influenza in Hospitalized Patients
Yanamala, N., Krishna, N. H., Hathaway, Q. A., Radhakrishnan, A., Sunkara, S., Patel, H., Farjo, P., Patel, B., Sengupta, P. P.
10.1101/2021.01.13.21249540 — Posted: 2021-01-15
Anticipating the curve: can online symptom-based data reflect COVID-19 case activity in Ontario, Canada?
Maharaj, A. S., Parker, J., Hopkins, J. P., Gournis, E., Bogoch, I., Rader, B., Astley, C. M., Ivers, N. M., Hawkins, J. B., Lee, L., Tuite, A., Fisman, D. N., Brownstein, J. S., Lapointe-Shaw, L.
10.1101/2021.01.15.21249879 — Posted: 2021-01-15
Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19
Wang, J., Kotagiri, P., Lyons, P., Mescia, F., Bergamaschi, L., Turner, L., Al-Lamki, R., Morgan, M. D., Calero-Nieto, F. J., Bach, K., Mende, N., Wilson, N. K., Watts, E. R., Cambridge Institute of Therapeutic Immunology and Infectious Disease - NIHR Covid BioResource, , Chinnery, P., Kingston, N., Papadia, S., Stirrups, K., Walker, N., Gupta, R. K., Toshner, M., Weekes, M., Nathan, J. A., Walmsley, S., Ouwehand, W. H., Kasanicki, M., Gottgens, B., Marioni, J. C., Smith, S. G., Pober, J. S., Bradley, J. R.
10.1101/2021.01.14.21249801 — Posted: 2021-01-15
Antibiotic Prescribing Patterns at COVID-19 Dedicated Wards in Bangladesh: A Single Center Point-Prevalence Survey
Molla, M. M. A., Yeasmin, M., Islam, M. K., Sharif, M. M., Amin, M. R., Nafisa, T., Ghosh, A. K., Parveen, M., Arif, M. M. H., Alam, J. A. J., Rizvi, S. J. R., Saif-Ur-Rahman, K., Akram, A., Shamsuzzaman, A.
10.1101/2021.01.15.21249868 — Posted: 2021-01-15
How to best test suspected cases of COVID-19: an analysis of the diagnostic performance of RT-PCR and alternative molecular methods for the detection of SARS-CoV-2
Mironas, A., Jarrom, D., Campbell, E., Washington, J., Ettinger, S., Wilbacher, I., Endel, G., Vrazic, H., Myles, S., Prettyjohns, M.
10.1101/2021.01.15.21249863 — Posted: 2021-01-15
SARS-CoV-2 infection control implementation based on sources of infection showing directions for three age groups in Japan
Hata, A., Kurita, J., Muso, E., Katayama, T., Hata, T., Ohkusa, Y.
10.1101/2021.01.14.21249637 — Posted: 2021-01-15
Sterilization of disposable face masks with respect to COVID-19 shortages; a nationwide field study including 19 sterilisation departments
van Straten, B., Robertson, D., Oussoren, H., Pereira Espindola, S. E., Ghanbari, E., Dankelman, J., Picken, S., Horeman, T.
10.1101/2021.01.15.21249843 — Posted: 2021-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).